Inside Financial News
No Result
View All Result
Wednesday, July 9, 2025
  • Home
  • News
    • Precious Metals
    • Battery Metals
    • Energy
    • Special Situation
    • Tech
    • Biotech
    • Crypto
  • Expert Opinions
    • Economy
    • Business
    • Markets
  • Contact Us
×

  • Home
  • News
    • Precious Metals
    • Battery Metals
    • Energy
    • Special Situation
    • Tech
    • Biotech
    • Crypto
  • Expert Opinions
    • Economy
    • Business
    • Markets
  • Contact Us
No Result
View All Result
Inside Financial News
No Result
View All Result
Home News Battery Metals

New cancer treatment trial shrinks Luton man’s brain tumour by half after just weeks of radioactive injections | UK News

by Inside Financial
October 29, 2024
in Battery Metals, Biotech, Crypto, Energy, Gadget, Markets, Politics, Precious Metals, Real Estate, Startup, Tech
0
New cancer treatment trial shrinks Luton man’s brain tumour by half after just weeks of radioactive injections | UK News
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

A new radioactive therapy has shrunk a man’s deadly brain tumour by half, in what experts hope could be a breakthrough cancer treatment.

Paul Read, a 62-year-old engineer from Luton, noticed he had a severe headache last December. Two weeks later, his wife Pauline was concerned he had a stroke as his face appeared to have dropped on one side.

He was diagnosed with recurrent glioblastoma – a type of brain cancer which kills most patients within 18 months – after doctors found a large mass on his brain.

Despite undergoing an operation on 27 December, followed by courses of radiotherapy and chemotherapy, Mr Read was told in July his tumour was growing again.

“I was fully expecting the tumour to return due to its aggressive nature,” he said. “I know the outcome isn’t great and I was happy to explore anything else.”

He was then offered the chance to become the first patient in a clinical trial aiming to cure the disease, run by the University College London Hospitals NHS Foundation Trust (UCLH).

In the CITADEL-123 trial, surgeons remove as much tumour as possible before implanting a small medical device called an Ommaya reservoir under the scalp, which connects to the tumour via a small tube.

The nuclear medicine team at UCLH then inject a drug – ATT001, which helps repair DNA damage in cells – directly into the tumour to deliver small amounts of radioactivity.

The drug, given weekly for four to six weeks, causes lethal damage to tumour cells but leaves healthy tissue unaffected.

Since starting the experimental treatment, Mr Read has seen his tumour shrink by half in just a matter of weeks.

“This trial was a lifeline, as the likelihood of survival according to the data was a year or less for me,” he said.

“I am delighted to be given the opportunity to be part of this trial and I have not experienced any side effects from the injections.”

“I am feeling very good,” the engineer added. He also said he’s not afraid of the treatment failing to cure his cancer if it can help others.

“We are all dealt a hand of cards and you don’t know which ones you are going to get,” he said.

“It will be wonderful if this treatment helps me and if it doesn’t, it doesn’t.

“I am more than happy – even it if doesn’t benefit me, it may benefit someone else down the line. So I have got nothing to lose and everything to hope for.”

Image:
Pic: PA

Dr Paul Mulholland, UCLH consultant medical oncologist who designed the trial, said the reduction of Mr Read’s tumour “is really quite remarkable for somebody whose tumour is so aggressive”.

“We have to aim to cure this disease,” he said. “Primary brain tumours do not metastasize around the body and generally stay in the same location in the brain.

“It doesn’t spread to the rest of the body, so using a targeted – directly into the tumour – approach makes sense.”

Read more:
Alzheimer’s drug rejected for widespread NHS use
Thousands denied weight loss jab due to slow rollout

Follow Sky News on WhatsApp

Keep up with all the latest news from the UK and around the world by following Sky News

Tap here

A second patient is currently undergoing the same procedure, with one being treated a month by the team, and Dr Mulholland said the trial aims to have up to 40 patients treated.

The dose of radiation will be increased throughout the trial and researchers plan to combine ATT001 with immunotherapy – which trains the body’s immune system to kill cancerous cells.

While he said early signs are promising, Dr Mulholland noted the trial is a “first-in-human study so we’ve been cautious in our approach and are only treating patients for six weeks”.

Source link

Previous Post

SBI's newly appointed chair C S Setty targets unbanked in expansion plans – Business Standard

Next Post

Jio Financial Services launches SmartGold on Dhanteras for investment in digital gold – Moneycontrol

Next Post
Global Stocks Advance as Tech Rally Continues: Markets Wrap

Jio Financial Services launches SmartGold on Dhanteras for investment in digital gold - Moneycontrol

Please login to join discussion

Twitter Feeds

  • Trending
  • Comments
  • Latest

Mining’s “Tom Brady” – Bob Dickinson Fuels Copper & Gold Discovery

January 31, 2025
Lithium M&A Continues with Rio Tinto’s $6.7 Billion Arcadium Lithium Acquisition – Lithium Explorers and Developers begin rallying

Lithium M&A Continues with Rio Tinto’s $6.7 Billion Arcadium Acquisition and Piedment Sayona $623 Million Merger – Lithium Explorers and Developers begin rallying

November 21, 2024

Billions are being committed to Hydrogen development in Canada and the USA with Hydrogen explorers and developers starting to rally – 4 Stocks that could benefit significantly

January 12, 2025

THE M&A BOOM THAT NEVER STOPS BOOMING

February 21, 2025

High Street Retailers Pin Hopes On Discount Splurge In Black Friday Fever

0

UK Faces Two Decades of No Earnings Growth and More Austerity

0

High-Speed Traders In Search of New Markets Jump Into Bitcoin

0

Brexit Has Created A Political Climate No Budget Can Fix

0

Institutional Bitcoin Adoption Accelerates: Hyper Bit Technologies Steps Into the Spotlight

June 23, 2025

Uranium Powers Up: Meta’s Nuclear Deal Sparks New Era for AI and Energy Security

June 23, 2025
Crypto’s Wild Ride and the Crypto Miners that are the backbone of an industry

Crypto’s Wild Ride and the Crypto Miners that are the backbone of an industry

May 22, 2025
4 Copper Stocks to Watch as Copper Hits $4.80 per Pound.

4 Copper Stocks to Watch as Copper Hits $4.80 per Pound.

March 11, 2025

Recent News

Institutional Bitcoin Adoption Accelerates: Hyper Bit Technologies Steps Into the Spotlight

June 23, 2025

Uranium Powers Up: Meta’s Nuclear Deal Sparks New Era for AI and Energy Security

June 23, 2025

Categories

  • Acquisition
  • Aviator
  • Battery Metals
  • Biotech
  • Business
  • Copper
  • Crypto
  • Economy
  • Energy
  • Expert Opinions
  • Finance News
  • Gadget
  • Gold
  • Lithium
  • Markets
  • Mining
  • News
  • Politics
  • Precious Metals
  • Real Estate
  • Special Situation
  • Startup
  • Stocks News
  • Tech
  • Tech
  • Uncategorized

Site Navigation

  • Home
  • Advertisement
  • Contact Us
  • Privacy & Policy
  • Other Links
Inside Financial News

We bring you the best website that perfect for news, magazine, personal blog, etc. Check our landing page for details.

© 2025 Inside Financial News

No Result
View All Result
  • Home
  • News
    • Precious Metals
    • Battery Metals
    • Energy
    • Special Situation
    • Tech
    • Biotech
    • Crypto
  • Expert Opinions
    • Economy
    • Business
    • Markets
  • Contact Us

© 2025 Inside Financial News

Subscribe Now For A Chance To Win Big!